I-Mab Biopharma
IMAB
$1.76
Share price
0.00%
Change (1 day)
-43.97%
Change (1 year)
Categories
I-Mab Biopharma (IMAB) - Cash on Hand
Cash on Hand as of June 2023 : $0.40 B
According to I-Mab Biopharma's latest financial reports the company has $0.40 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
I-Mab Biopharma - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.50 B | -25.48% |
| 2021-12-31 | $0.67 B | -8.62% |
| 2020-12-31 | $0.73 B | 338.72% |
| 2019-12-31 | $0.16 B | -37.57% |
| 2018-12-31 | $0.26 B | 203.85% |
| 2017-12-31 | $88.25 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | -76.39% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -94.87% | 🇺🇸 USA |